Cardio Diagnostics Expands Access to Precision Heart Disease Tests Through Atlas Healthcare Physicians

Cardio Diagnostics Holdings (NASDAQ: CDIO), a company specializing in AI-powered precision cardiovascular medicine, announced that Atlas Healthcare Physicians, an independent physician association serving managed care populations in Los Angeles and Orange counties, will cover the company’s Epi+Gen CHD and PrecisionCHD tests for eligible members with prior authorization. This move expands access to noninvasive blood tests designed to assess coronary heart disease risk and support personalized treatment planning.

The Epi+Gen CHD test evaluates a patient’s three-year risk of a coronary heart disease event, while PrecisionCHD helps diagnose coronary heart disease and identify its underlying molecular drivers. Both tests are blood-based and do not require fasting or radiation exposure, making them easier to integrate into routine care. The partnership with Atlas Healthcare Physicians, which serves a diverse managed care population, is expected to broaden the adoption of precision cardiovascular medicine in community healthcare settings.

“This collaboration reflects our commitment to making advanced cardiovascular diagnostics more accessible to patients who need them,” said a spokesperson from Cardio Diagnostics. “By working with Atlas Healthcare Physicians, we can bring our precision tests to a larger population, potentially improving early detection and management of coronary heart disease.”

The announcement underscores the growing trend of integrating precision medicine into managed care networks. With cardiovascular disease remaining a leading cause of death in the U.S., tools that enable earlier and more accurate risk assessment are critical. The Epi+Gen CHD and PrecisionCHD tests offer a noninvasive alternative to traditional diagnostic methods, which often involve imaging or invasive procedures.

Cardio Diagnostics’ proprietary technology leverages an AI-driven Integrated Genetic-Epigenetic Engine to analyze blood samples. This approach aims to provide personalized insights into cardiovascular health, moving beyond one-size-fits-all risk factors. The company believes that such precision can lead to better outcomes and more efficient use of healthcare resources.

The coverage expansion comes as Cardio Diagnostics continues to build its commercial footprint. For more information about the company and its tests, visit their newsroom at https://nnw.fm/CDIO. The full press release is available at https://nnw.fm/EFQen.

As precision medicine gains traction, partnerships like this one between Cardio Diagnostics and Atlas Healthcare Physicians could pave the way for broader insurance coverage and patient access to advanced diagnostics. The implications extend beyond individual patient care, potentially reducing healthcare costs by preventing costly cardiovascular events through early intervention.

This news story relied on content distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is Cardio Diagnostics Expands Access to Precision Heart Disease Tests Through Atlas Healthcare Physicians.

The post Cardio Diagnostics Expands Access to Precision Heart Disease Tests Through Atlas Healthcare Physicians appeared first on citybuzz.